Cell Constraint Cancer
  • Home
  • Company
    • History & Perspectives
    • Governance
    • Partners
  • Innovation
    • Context
    • Principles
    • Our advances
    • Bibliography
  • Investors
    • Our needs
    • WHY INVEST
    • Financial documents
  • Français
Select Page

Results for the 2nd Quarter 2019

by Barthélémy Brossel | 17 Jul 2019 | 2019 Press Releases, Business News, Homepage slider, Scientific Publications

– FOLLOWING THE FAILURE OF OUR APPLICATION FOR A EUROPEAN SUBSIDY, ONE OF OUR SHAREHOLDER COMMITS TO RAISE THE BUDGET FOR PROOF OF EFFICACY – CC & C RECEIVES DELIVERANCE OF ITS PATENT FOR JAPAN AND THE USA On June 20th, we received the notification of...

Results for the 1st Quarter 2019

by Christine Grau | 21 May 2019 | 2019 Press Releases, Business News, Homepage slider, Scientific Publications

– SHAREHOLDERS TO APPROVE TOD FINANCES’ INVESTMENT IN CC&C – CC & C GETS CERTIFICATION BY ITS COMPETITIVENESS CLUSTER We held our General Assembly on May 9th.This was mainly an opportunity to ratify family office “TOD Finances” investment in...

Recent Posts

  • Results for the 2nd Quarter 2019
  • Results for the 1st Quarter 2019
  • Results for the 4th quarter 2018
  • Results for the 3rd quarter 2018
  • Proof of efficacy for dummies

Categories

  • 2018 Press Releases
  • 2019 Press Releases
  • Business News
  • Homepage slider
  • Scientific Publications
  • Facebook
  • Twitter
  • Google
  • RSS

Designed by Elegant Themes | Powered by WordPress

Utilisation des cookies
Nous utilisons des cookies pour simplifier votre navigation sur note site. En utilisant le site, vous acceptez le recours aux cookies.
Ok